Willemze R - Search Results

1

Cytomegalovirus antigenemia assay or PCR can be used to monitor ganciclovir treatment in bone marrow transplant recipients.

Vlieger AM, Boland GJ, Jiwa NM, de Weger RA, Willemze R, de Gast GC, Falkenburg JH. Vlieger AM, et al. Among authors: willemze r. Bone Marrow Transplant. 1992 Apr;9(4):247-53. Bone Marrow Transplant. 1992. PMID: 1318141

2

Epstein-Barr virus infection in allogeneic marrow grafting: lessons for transplant physicians and virologists.

Gratama JW, Oosterveer MA, Lepoutre J, Fibbe WE, Ringdén O, Vossen JM, Willemze R, Bolhuis RL, van Rood JJ, Ernberg I. Gratama JW, et al. Among authors: willemze r. Ann Hematol. 1992 Jun;64 Suppl:A162-5. doi: 10.1007/BF01715373. Ann Hematol. 1992. PMID: 1322190

3

High incidence of EBV genome in CD30-positive non-Hodgkin's lymphomas.

Kanavaros P, Jiwa NM, de Bruin PC, van der Valk P, Noorduyn LA, van Heerde P, Gordijn R, Horstman A, Mullink R, Willemze R, et al. Kanavaros P, et al. Among authors: willemze r. J Pathol. 1992 Nov;168(3):307-15. doi: 10.1002/path.1711680311. J Pathol. 1992. PMID: 1335046

4

Sustained engraftment of mice transplanted with IL-1-primed blood-derived stem cells.

Fibbe WE, Hamilton MS, Laterveer LL, Kibbelaar RE, Falkenburg JH, Visser JW, Willemze R. Fibbe WE, et al. Among authors: willemze r. J Immunol. 1992 Jan 15;148(2):417-21. J Immunol. 1992. PMID: 1345921

5

Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia.

Faber LM, van Luxemburg-Heijs SA, Willemze R, Falkenburg JH. Faber LM, et al. Among authors: willemze r. J Exp Med. 1992 Nov 1;176(5):1283-9. doi: 10.1084/jem.176.5.1283. J Exp Med. 1992. PMID: 1402674 Free PMC article.

6

Longitudinal analysis of point mutations of the N-ras proto-oncogene in patients with myelodysplasia using archived blood smears.

van Kamp H, de Pijper C, Verlaan-de Vries M, Bos JL, Leeksma CH, Kerkhofs H, Willemze R, Fibbe WE, Landegent JE. van Kamp H, et al. Among authors: willemze r. Blood. 1992 Mar 1;79(5):1266-70. Blood. 1992. PMID: 1536950 Free article.

7

Human interleukin for DA cells (HILDA) does not affect the proliferation and differentiation of hematopoietic progenitor cells in human long-term bone marrow cultures.

Schaafsma MR, Falkenburg JH, Duinkerken N, Moreau JF, Soulillou JP, Willemze R, Fibbe WE. Schaafsma MR, et al. Among authors: willemze r. Exp Hematol. 1992 Jan;20(1):6-10. Exp Hematol. 1992. PMID: 1577095

8

In vivo use of Campath-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation.

Willemze R, Richel DJ, Falkenburg JH, Hale G, Waldmann H, Zwaan FE, Fibbe WE. Willemze R, et al. Bone Marrow Transplant. 1992 Apr;9(4):255-61. Bone Marrow Transplant. 1992. PMID: 1600413

9

Effect of mast cell growth factor (c-kit ligand) on clonogenic leukemic precursor cells.

Goselink HM, Williams DE, Fibbe WE, Wessels HW, Beverstock GC, Willemze R, Falkenburg JH. Goselink HM, et al. Among authors: willemze r. Blood. 1992 Aug 1;80(3):750-7. Blood. 1992. PMID: 1638026 Free article.

10

Patients with aplastic anemia (AA) before or after treatment with anti-thymocyte globulin (ATG) may exhibit clonal hematopoiesis.

van Kamp H, Landegent JE, Willemze R, Fibbe WE. van Kamp H, et al. Among authors: willemze r. Bone Marrow Transplant. 1991;7 Suppl 2:99. Bone Marrow Transplant. 1991. PMID: 1678979 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

804 results

Search Page

Filters